Skip to main content

HUTCHMED (China) Ltd

HCM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001648257

No open-market purchases or sales by HUTCHMED (China) Ltd insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $46.5M in total; no superinvestor holds it.

Other share classesHMDCF

Q1 2025 vs. Q4 2024

How the institutions holding HUTCHMED (China) Ltd changed between Q4 2024 and Q1 2025.

All holders in Q1 2025All holders in Q4 2024

13F holders of HCM: Q4 2024 compared with Q1 2025
MeasureQ4 2024Q1 2025Change
Holders7063−7
Shares6.90M6.60M−299.1K (−4.3%)
Value$99.3M$99.9M+$581.4K (+0.6%)

New holders (2)

Institutions that held HUTCHMED (China) Ltd at the end of Q1 2025 but not at the end of Q4 2024.

Institutions new to HCM in Q1 2025
InstitutionSharesValue% of portfolio
Nisa Investment Advisors, LLC300$4.51K0.00%
Coldstream Capital Management Inc102$1.53K0.00%

Sold out (9)

Institutions that held HUTCHMED (China) Ltd at the end of Q4 2024 and filed for Q1 2025 without it.

Institutions that sold out of HCM in Q1 2025
InstitutionShares, Q4 2024Value, Q4 2024
D. E. Shaw & Co., Inc.41,543$598.6K
Barometer Capital Management Inc.10,900$186.6K
Northern Trust Corp10,980$158.2K
Aquatic Capital Management LLC1,022$14.7K
Eagle Bay Advisors LLC200$2.88K
Farther Finance Advisors, LLC147$2.12K
Quadrant Capital Group LLC31$447
Creekmur Asset Management LLC19$274
IFP Advisors, Inc0$173